Travere Therapeutics, Inc. · NASDAQ:TVTX
Coughlin Timothy sold 10,000 Travere Therapeutics, Inc. shares (Form 4)
Traded Jun 12, 2026 · Filed Jun 16, 2026
On Jun 12, 2026, Coughlin Timothy (Director) sold 10,000 Travere Therapeutics, Inc. shares at US$50.07 for US$501K under a trading plan, leaving 56,250 shares. Filed Jun 16, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$50.07
- Value
- US$501K
- Holding after
- 56,250 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Option exercise | 10,000 | US$26.52 | 66,250 | Direct |
| Jun 12, 2026 | Common Stock | Sale | 10,000 | US$50.07 | 56,250 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Coughlin Timothy
- Travere Therapeutics, Inc. shareholders
- Form 4 · Coughlin Timothy · May 21, 2026
- Form 4 · Coughlin Timothy · May 19, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026